PSC
VTVT icon

Piper Sandler & Co’s vTv Therapeutics VTVT Stock Holding History

Piper Sandler & Co’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.31M Sell
4,555
-6,470
-59% -$1.56M 2.51% 5
2016
Q2 		$2.56M Sell
11,025
-4,379
-28% -$1.01M 10.99% 2
2016
Q1 		$3.18M Sell
15,404
-1,746
-10% -$435K 6.9% 5
2015
Q4 		$4.67M Sell
17,150
-2,231
-12% -$626K 11.86% 3
2015
Q3 		$5.05M Buy
+19,381
New +$6.75M 5.4% 6

Other funds holding VTVT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Piper Sandler & Co's VTVT Position: Q3 2016 in Review

Piper Sandler & Co reduced its vTv Therapeutics (VTVT) stake by 59% in Q3 2016, selling an estimated $1.56M and leaving 4,555 shares worth $1.31M. The position accounts for 2.51% of the portfolio, ranked #5.

Piper Sandler & Co first reported a position in VTVT in Q3 2015 and has held it in 5 quarters since. The position peaked at $5.05M in Q3 2015. 36 funds tracked by Wall St. Rank hold VTVT as of Q3 2016.

  • Piper Sandler & Co held 4,555 shares of vTv Therapeutics worth $1.31M as of Q3 2016.
  • Piper Sandler & Co sold 6,470 vTv Therapeutics shares in Q3 2016, an estimated $1.56M.
  • vTv Therapeutics made up 2.51% of Piper Sandler & Co's portfolio in Q3 2016, its #5 holding.
  • Piper Sandler & Co first reported a position in vTv Therapeutics in Q3 2015 and has held it in 5 quarters since.
  • Piper Sandler & Co's vTv Therapeutics position peaked at $5.05M in Q3 2015.
  • 36 funds tracked by Wall St. Rank held vTv Therapeutics as of Q3 2016.

Based on Piper Sandler & Co's 13F filing for Q3 2016, filed 14 Nov 2016.